SILVER SPRING, Md. — Each year, the Reagan-Udall Foundation for the FDA conducts an Annual Public Meeting of its Board of Directors to share information about our activities in support of the U.S. Food and Drug Administration. By bringing together a variety of perspectives, the annual public meeting facilitates engagement between FDA and external stakeholders including patients and consumers, regulated industry, health care providers, academics and others dedicated to improving America's public health. This meeting is open to the public, but advance registration is required.
Join to gain a greater understanding of the FDA's priorities from Robert M. Califf, MD, Commissioner, Food and Drugs, as well as other senior FDA personnel. You'll also hear updates on the Foundation's growing portfolio of activities over the past year from the Foundation leadership.
In what promises to be an engaging discussion, Foundation CEO Susan C. Winckler will moderate a panel of key FDA leaders as they share their thoughts on the Agency's ongoing work in a changing regulatory landscape. Panelists include:
- Namandjé Bumpus, Chief Scientist
- Hilary Charston, Chief Medical Officer
- Mark Raza, Chief Counsel
- Julie Tierney, Chief of Staff